Author:
Cao Huifang,Zhang Lichao,Qu Zhenzhen,Tian Shuang,Wang Zhiyong,Jiang Yuhang,Hou Qian,Jia Lijing,Wang Weiping
Funder
Hebei Medical University
National Natural Science Foundation of China
Subject
Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience
Reference61 articles.
1. Ashkenazi, A., Fairbrother, W.J., Leverson, J.D., Souers, A.J., 2017. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat. Rev. Drug Discov. 16, 273-284. Doi: 10.1038/nrd.2016.253.
2. Zonisamide add-on therapy for focal epilepsy;Brigo;Cochrane Database Syst Rev.,2018
3. Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., 2016. Nrf2-ARE pathway: An emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol. Ther. 157, 84-104. Doi: 10.1016 / j.pharmthera.2015.11.003.
4. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease;Cai;J. Neurosci. Res.,2008
5. The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease;Calkins;Antioxid. Redox Signal.,2009
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献